glp 1 agonist medications GLP-1s for Weight Loss: What You Need to Know GLP-1 Drugs for Weight Loss:

Incretin hormones in obesity and related cardiometabolic disorders: the clinical perspective

Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts

Soluble Dipeptidyl Peptidase-4 Induces Microvascular Endothelial Dysfunction through Proteinase-Activated Receptor-2 and Thromboxane A2 Release

Behavioral support (addressing eating behaviors, emotional triggers, psychological wellbeing) remains crucial for adherence and long-term success

Serious side effects are rare but may include severe allergic reactions (anaphylaxis) or inflammation of the pancreas (pancreatitis)

Retatrutide and other triple agonists are fully synthetic compounds designed to engage multiple receptors simultaneously